Infographic: The Changing Infant Gut Microbiome
Infographic: The Changing Infant Gut Microbiome

Infographic: The Changing Infant Gut Microbiome

The microbial makeup of a newborn baby’s intestines has changed dramatically over the past 100 years, and we are now beginning to understand how and why this matters.

Jennifer T. Smilowitz and Diana Hazard Taft
Jun 1, 2020

ABOVE: © LAURIE O'KEEFE

Historically, the breastfed infant gut microbiome was a near monoculture of Bifidobacterium. The formula-fed infant gut microbiome was much more diverse. The breastfed infant gut microbiome and the formula-fed infant gut microbiome are now more similar to the historical formula-fed infant gut microbiome, although modern breastfed infants do have more Bifidobacterium than modern formula-fed infants.

© istock.com, bubaone; © istock.com, A-Digit

The Milk-Oriented Microbiome

Human milk oligosaccharides (HMOs) are complex carbohydrates that microbial species of the milk-oriented microbiome (MOM) can use as  a food source. Bifidobacterium infantis encodes many proteins that specifically bind and transport all types of HMOs into its cell and digest them internally. Other Bifidobacterium species digest only some HMOs and some do so externally. Digestion of HMOs by MOM Bifidobacterium results in the production of lactate and the short chain fatty acid acetate, that are secreted into the gut lumen. These molecules lower the pH in the intestinal milieu, which improves their transport into the epithelium for use by the host and creates an undesirable environment for potential pathogens such as E. coli

© laurie o’keefe

B. infantis

© laurie o’keefe

B. infantis preferentially consumes all HMO species over any other carbohydrate source.

  1. Binding proteins glom on to HMOs and usher the carbohydrates to transporters that move them into the bacterial cell.
  2. Intracellular glycosyl hydrolases cleave each glycosidic linkage
    of all HMO structures, yielding monosaccharides.
  3. These monosaccharides are metabolized into acetate and lactate that are secreted from the cell.

B. bifidum

© laurie o’keefe

B. bifidum eats only a subset of HMOs.

  1. Glycosyl hydrolases attached to the outer cell membrane break down
    HMOs into mono- and disaccharides in the extracellular space.
  2. These molecules are imported via transporters, and some are gobbled up by other intestinal microbes, a process called cross-feeding. 
  3. The mono- and disaccharides are further metabolized into acetate and lactate, though because B. bifidum is a less efficient consumer of HMOs, it likely produces less of these products than B. infantis.

Read the full story.

Jennifer Smilowitz is the associate director of the Human Studies Research Program at the Foods for Health Institute and a research scientist in the Department of Food Science and Technology at the University of California, Davis. Diana Hazard Taft is a postdoctoral research fellow in David Mills’s lab in the Department of Food Science and Technology and a member of the Foods for Health Institute at UC Davis.